Pharmacopeia, Inc. Explained

Pharmacopeia was a public biotechnology company that pioneered the field of small molecule combinatorial chemistry.

Pharmacopeia was founded by Larry Bock and Drs. Michael Wigler, Clark Still and Jack Chabala.

Pharmacopeia went public in 1996 and was acquired by Ligand Pharmaceuticals[1] on December 13, 2008.

Notes and References

  1. Web site: Myers . Calisha . September 25, 2008 . Ligand Pharmaceuticals Inc. to Acquire Pharmacopeia, Inc. for Stock and Contingent Value Rights for $70M . Fierce Biotech.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pharmacopeia, Inc.".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.